Reading Time: 3 minutesA recent press release by the pharmaceutical company Biogen reported preliminary results from an ongoing clinical trial investigating a form of precision therapy in people
Category: Clinical Trials
Reading Time: 10 minutes“The annals of ALS clinical trials is strewn with failed studies. Only two out of more than 70 clinical trials have been positive, and even
Reading Time: 7 minutesIs it possible that a drug that treats congestive heart failure could improve respiration in people with MND? Or that a drug used to treat
Reading Time: 7 minutesIn November 2018 the Home Office released a draft Guideline scope for Cannabis-based products for medicinal use in which they announced that specialist doctors (like
Reading Time: 5 minutesThere has recently been a flood of news stories on the outcomes of the Australian Phase 1 clinical trial investigating Copper ATSM (CuATSM) which is
Reading Time: 3 minutesThis blog is part of the ‘Highlights from Glasgow’ collection of articles, where you can read about the content of some of the talks and
Reading Time: 2 minutesIn their official press release published on 21 November 2017, Cytokinetics Inc. announced that they will not be continuing work on tirasemtiv after disappointing results
Causes and disease mechanisms Clinical Trials Markers of Disease Progression MND Research Research we fund
Lighthouse Project shines a beacon on HERVs and their role in ALS
Reading Time: 3 minutesThere is recent evidence to suggest that Human Endogenous Retroviruses (HERVs) may be involved in amyotrophic lateral sclerosis (ALS). HERV-K has been directly linked to
Reading Time: 5 minutesIt’s been over a month since the announcement by the FDA of their decision to licence edaravone / Radicava for people with MND in the
Reading Time: 4 minutesEach year, the MND Association dedicates the month of June to raising MND awareness. This year, we focus on the eyes – in most people